Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Folate fortification benefits to elderly "greatly outweigh expected risk" -- JAMA study.

This article was originally published in The Tan Sheet

Executive Summary

Tucker et al. noted that pernicious anemia, an extreme form of vitamin B12 deficiency, has been successfully treated with oral doses of 300-1,000 mcg of cobalamin with no evidence of toxic adverse effects. "Our results support the argument that the addition of cobalamin to supplements containing folic acid would be a prudent action," they said.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086472

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel